The candidate HCV E1E2MF59 vaccine enhances 2nd phase viral decline in responders to PEG-IFN/ribavirin
Titel:
The candidate HCV E1E2MF59 vaccine enhances 2nd phase viral decline in responders to PEG-IFN/ribavirin
Auteur:
Colombatto, P. Brunetto, M.R. Maina, A.M. Romagnoli, V. Craxì, A. Almasio, P. Madonia, S. Rumi, M.G. Colombo, M. Fargion, S. Ascione, A. Pinzello, G. Mondelli, M. Muzzi, A. Bianchi, F. Barnaba, V. Sarracino, M. Rappuoli, R. Rosa, D. Montigiani, S. Abrignani, S. Houghton, M. Bonino, F.